Literature DB >> 21815198

Signal transducer and activator of transcription 1 (Stat1) maintains basal mRNA expression of pro-survival stat3-target genes in glioma C6 cells.

Alicja Adach-Kilon1, Karolina Swiatek-Machado, Bozena Kaminska, Michal Dabrowski.   

Abstract

The STAT proteins (signal transducers and activators of transcription) are transcription factors mediating cytokine/growth factor signaling, which play important role in controlling cell cycle progression and apoptosis. In many cancer cell lines and tumors (including gliomas) the STAT proteins (in particular Stats 1, 3, and 5) are persistently activated. In this study, we employed DNA decoys, siRNAs, and protein overexpression, to elucidate the role of Stat1 and Stat3 in regulation of expression of endogenous Stat3-target genes (Bcl2l1, Myc, Ccnd1) and a Stat-driven reporter plasmid, in rat C6 glioma cells. The results obtained with the decoys and siRNA suggest that in proliferating C6 cells, Stat1 supports the basal expression of Bcl2l1, while the decoy and chromatin immunoprecipitation results suggest it also plays a similar role for Myc. In the Stat-driven reporter system, overexpression of Stat1 stimulated, while overexpression of Stat3 inhibited the reporter gene expression. The level of Stat1 phosphorylation observed under basal conditions in proliferating glioma C6 cells is very low. Therefore, we speculate that it is the activity of the unphosphorylated Stat1 that is inhibited by Stat1 decoy or Stat1 siRNA. Taken together, our results demonstrate that it is Stat1 not Stat3 that maintains the expression of Bcl2l1 and possibly Myc in proliferating glioma C6 cells. An established paradigm is that Stat3 exerts a pro-survival and potentially oncogenic effects, while Stat1 is mainly associated with the immune response. Our results add to a number of reports that challenge this paradigm.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21815198     DOI: 10.1002/jcb.23305

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Cancer progression modeling using static sample data.

Authors:  Yijun Sun; Jin Yao; Norma J Nowak; Steve Goodison
Journal:  Genome Biol       Date:  2014-08-26       Impact factor: 13.583

2.  Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.

Authors:  Qifang Zhang; Dewan Md Sakib Hossain; Priyanka Duttagupta; Dayson Moreira; Xingli Zhao; Haejung Won; Ralf Buettner; Sergey Nechaev; Marcin Majka; Bin Zhang; Qi Cai; Piotr Swiderski; Ya-Huei Kuo; Stephen Forman; Guido Marcucci; Marcin Kortylewski
Journal:  Blood       Date:  2016-01-21       Impact factor: 22.113

3.  Natural product HTP screening for attenuation of cytokine-induced neutrophil chemo attractants (CINCs) and NO2- in LPS/IFNγ activated glioma cells.

Authors:  Elizabeth A Mazzio; David Bauer; Patricia Mendonca; Equar Taka; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2016-12-01       Impact factor: 3.478

4.  A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line.

Authors:  Inès Souissi; Patrick Ladam; Jean A H Cognet; Stéphanie Le Coquil; Nadine Varin-Blank; Fanny Baran-Marszak; Valeri Metelev; Remi Fagard
Journal:  Mol Cancer       Date:  2012-03-16       Impact factor: 27.401

Review 5.  The role of JAK-STAT signaling within the CNS.

Authors:  Celine S Nicolas; Mascia Amici; Zuner A Bortolotto; Andrew Doherty; Zsolt Csaba; Assia Fafouri; Pascal Dournaud; Pierre Gressens; Graham L Collingridge; Stephane Peineau
Journal:  JAKSTAT       Date:  2013-01-01

6.  Off-target effects of plasmid-transcribed shRNAs on NFκB signaling pathway and cell survival of human melanoma cells.

Authors:  Kavita Ramji; Dorota Weronika Kulesza; Salem Chouaib; Bozena Kaminska
Journal:  Mol Biol Rep       Date:  2013-10-30       Impact factor: 2.316

7.  Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data.

Authors:  Chia-Lang Hsu; Hsin-Yi Chang; Jen-Yun Chang; Wen-Ming Hsu; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Oncotarget       Date:  2016-06-14

8.  The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study.

Authors:  Michael Itak Ita; Jiang Huai Wang; André Toulouse; Chris Lim; Noel Fanning; Michael O'Sullivan; Yvonne Nolan; George Finbarr Kaar; Henry Paul Redmond
Journal:  Acta Neurochir (Wien)       Date:  2021-10-13       Impact factor: 2.816

9.  Inhibition of a novel specific neuroglial integrin signaling pathway increases STAT3-mediated CNTF expression.

Authors:  Matthew P Keasey; Seong Su Kang; Chiharu Lovins; Theo Hagg
Journal:  Cell Commun Signal       Date:  2013-05-21       Impact factor: 5.712

10.  Prediction and identification of novel HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from endocan.

Authors:  Gaohai Shao; Qingjun Liu; Ling Yang; Guibo Feng; Wang Zhao; Zhongyan Huang; Zhao Yang
Journal:  J Inflamm (Lond)       Date:  2020-02-19       Impact factor: 4.981

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.